/Lists

Late Stage Investors & VC Firms in New York

165 firms in this list, with a median first check of $4M. 40 of them lead rounds. Generated from verified public data and updated continuously.

Open Field Capital
New YorkSeed–Late Stage
3 people
Innovatus Capital Partners
New YorkSeed–Late Stage
19 people
Second Alpha Partners
New YorkGrowth–Late Stage
6 people
Scion Life Sciences
New YorkSeed–Late Stage$1K – $60M
12 people
Centre Street Partners
New YorkGrowth–Late Stage$100K – $500K
6 people
atai Life Sciences
New YorkSeed–Late Stage
16 people
GreenPoint Partners
New YorkSeed–Late Stage
16 people
Bloom8
New YorkSeed–Late Stage
8 people
Alkeon Capital
New YorkSeed–Late Stage
4 people
Conversion Venture Capital (CVC2)
New YorkGrowth–Late Stage$2M – $25M
4 people
Corner Ventures
New YorkSeed–Late Stage
15 people
Access Biotechnology
New YorkSeed–Late Stage
4 people
Amzak Health
New YorkPre-Seed–Late Stage
5 people
Recharge Thematic Ventures Management Llc
New YorkSeed–Late Stage
8 people
Evidity Health Capital
New YorkGrowth–Late Stage$5M
5 people
Janus Henderson Investors
LondonLate Stage
Embedded Capital
New YorkGrowth–Late Stage$500K – $4M
8 people
GPO Fund
New YorkSeries C–Late Stage$5M – $10M
6 people
VIEWPOINT VENTURES
New YorkSeries B–Late Stage
8 people
HSCM Ventures
New YorkSeed–Late Stage
8 people
Altra Venture
New YorkSeries B–Late Stage$500K – $25M
2 people
Irving Investors
New YorkGrowth–Late Stage
8 people
Almanac Insights
New YorkSeed–Late Stage
3 people
Disruptive Ventures
New YorkSeed–Late Stage
3 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.